Intrinsic Value of S&P & Nasdaq Contact Us

Denali Therapeutics Inc. DNLI

NASDAQ Global Select

SharesGrow Score
62/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$34.40
+70.6%

Denali Therapeutics Inc. (DNLI) current share price is $20.16. The gold spot price is $4,808.10 per troy ounce. Using the formula: DNLI in gold = $20.16 × 31.1035 ÷ $4,808.10 = 0.1304 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of DNLI when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding DNLI shares over the measured period.

DNLI in US Dollars
Gold in US Dollars
DNLI in Gold (grams per share)

Real Wealth Growth Rate

DNLI
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{DNLI}_{\text{gold}}(t) = \frac{P_{\text{DNLI}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{DNLI}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{DNLI}_{\text{gold}}^{(T)}}{\text{DNLI}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{DNLI}_\text{gold}^{(0)}$ = initial gold-price, $\text{DNLI}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

RVMD
RVMD
Revolution Medicines, Inc.
$147.01
+7.86%
BGNE
BGNE
BeiGene, Ltd.
$184.71
+0.49%
ASND
ASND
Ascendis Pharma A/S
$249.84
+0.52%
PCVX
PCVX
Vaxcyte, Inc.
$62.76
+1.64%
BPMC
BPMC
Blueprint Medicines Corporation
$129.46
+0.14%
CERE
CERE
Cerevel Therapeutics Holdings, Inc.
$44.96
+0.74%
APLS
APLS
Apellis Pharmaceuticals, Inc.
$40.85
+0.02%
AKRO
AKRO
Akero Therapeutics, Inc.
$54.65
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message